Tower Research Capital LLC (Trc) Harpoon Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.55 - $0.82 $1,779 - $2,653	3,236 Added 31.63%	13,468 $9,000
Q1 2023 May 09, 2023	SELL	$0.65 - $1.37 $2,376 - $5,008	-3,656 Reduced 26.32%	10,232 $8,000
Q4 2022 Feb 10, 2023	BUY	$0.6 - $1.41 $5,050 - $11,869	8,418 Added 153.89%	13,888 $10,000
Q3 2022 Nov 10, 2022	BUY	$0.94 - $2.56 $268 - $732	286 Added 5.52%	5,470 $6,000
Q2 2022 Aug 15, 2022	BUY	$1.78 - $5.02 $5,459 - $15,396	3,067 Added 144.87%	5,184 $9,000
Q1 2022 May 12, 2022	SELL	$3.54 - $8.08 $2,502 - $5,712	-707 Reduced 25.04%	2,117 $11,000
Q4 2021 Feb 14, 2022	SELL	$5.69 - $7.83 $79,142 - $108,907	-13,909 Reduced 83.12%	2,824 $21,000
Q3 2021 Nov 15, 2021	BUY	$7.88 - $14.0 $114,401 - $203,252	14,518 Added 655.44%	16,733 $132,000
Q2 2021 Aug 16, 2021	BUY	$13.81 - $23.25 $17,400 - $29,295	1,260 Added 131.94%	2,215 $31,000
Q1 2021 May 17, 2021	SELL	$17.65 - $24.16 $77,995 - $106,763	-4,419 Reduced 82.23%	955 $20,000
Q4 2020 Feb 16, 2021	SELL	$12.83 - $17.84 $64,983 - $90,359	-5,065 Reduced 48.52%	5,374 $90,000
Q3 2020 Nov 16, 2020	BUY	$11.01 - $18.52 $97,460 - $163,939	8,852 Added 557.78%	10,439 $177,000
Q2 2020 Aug 13, 2020	BUY	$11.11 - $24.72 $17,631 - $39,230	1,587 New	1,587 $26,000
Q1 2020 May 15, 2020	SELL	$10.74 - $16.32 $18,999 - $28,870	-1,769 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$12.94 - $20.58 $1,953 - $3,107	-151 Reduced 7.86%	1,769 $26,000
Q3 2019 Nov 05, 2019	BUY	$10.93 - $17.47 $20,985 - $33,542	1,920 New	1,920 $26,000
Q2 2019 Aug 13, 2019	SELL	$10.0 - $13.03 $590 - $768	-59 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$9.47 - $17.01 $558 - $1,003	59 New	59 $1,000

Others Institutions Holding HARP

# of Institutions

Shares Held

353K

Call Options Held

Put Options Held

View Full List

About Harpoon Therapeutics, Inc.

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

More about HARP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account